We represented a publicly traded healthcare company in a strategic acquisition in which the target company had security vulnerabilities, followed almost immediately by a breach affecting the target’s legacy systems. The representation involved mitigation and response efforts, as well as navigating the company’s responses to its government investigation, ultimately leading to resolution with no penalties.